Milla Pharmaceuticals, Inc
FDA inspection history in White Bear Lake, Minnesota, 2026
- 1
- Form 483
Every document, by year
- Form 483
2026: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2026One Form 483, at White Bear Lake, Minnesota.
Cited most
Across all Milla Pharmaceuticals observations on file
- 21 CFR 314.80(b)Postmarketing reporting of adverse drug experiences1
The complete Milla Pharmaceuticals file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
White Bear Lake, Minnesota
One Form 483 · 2026 · 1 observation
Latest: Form 483, Mar 12, 2026 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2026-03-12 | 483 Form 483 | White Bear Lake, Minnesota | 1 | $99 |
Investigators on these documents
FEI number 3015401429 · most recent document Mar 12, 2026
About Milla Pharmaceuticals, Inc
How many FDA Form 483s has Milla Pharmaceuticals, Inc received?
FDA Intel has 1 Form 483 on file for Milla Pharmaceuticals, Inc; the most recent is dated Mar 12, 2026.
When was Milla Pharmaceuticals, Inc last inspected by FDA?
The most recent FDA inspection document on file for Milla Pharmaceuticals, Inc is a Form 483 dated Mar 12, 2026, for the site in White Bear Lake, Minnesota.
What did FDA cite at Milla Pharmaceuticals, Inc?
The regulations cited most in the observations on file for Milla Pharmaceuticals, Inc are 21 CFR 314.80(b) (Postmarketing reporting of adverse drug experiences), 1 time.